Susquehanna International Group, LLP Logic Bio Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.35 - $0.74 $2,980 - $6,302	8,517 Added 57.72%	23,272 $8,000
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $6,196 - $25,295	-10,159 Reduced 40.78%	14,755 $10,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.53 $46,774 - $96,312	-21,261 Reduced 46.04%	24,914 $58,000
Q3 2021 Nov 15, 2021	BUY	$3.85 - $5.09 $68,495 - $90,556	17,791 Added 62.68%	46,175 $211,000
Q2 2021 Aug 11, 2021	BUY	$4.03 - $7.57 $114,387 - $214,866	28,384 New	28,384 $126,000
Q1 2019 May 15, 2019	SELL	$7.93 - $10.41 $111,559 - $146,447	-14,068 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $110,855 - $252,942	14,068 New	14,068 $146,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.